MedPath

CLEAR CREEK BIO, INC.

CLEAR CREEK BIO, INC. logo
🇺🇸United States
Ownership
Private
Established
2017-01-01
Employees
11
Market Cap
-
Website
http://www.clearcreekbio.com

Clinical Trials

6

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 2
4 (66.7%)
Phase 1
2 (33.3%)

Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19

Phase 2
Terminated
Conditions
COVID-19
Interventions
First Posted Date
2021-12-22
Last Posted Date
2023-11-07
Lead Sponsor
Clear Creek Bio, Inc.
Target Recruit Count
26
Registration Number
NCT05166876
Locations
🇮🇳

RIMS - Government Medical College, Srikakulam, Andhra Pradesh, India

🇮🇳

King George Hospital, Visakhapatnam, Andhra Pradesh, India

🇮🇳

Global Hospital, Surat, Gujarat, India

and more 4 locations

CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

Phase 2
Completed
Conditions
COVID-19 Infection
Interventions
Drug: Placebo
First Posted Date
2020-10-05
Last Posted Date
2022-04-19
Lead Sponsor
Clear Creek Bio, Inc.
Target Recruit Count
115
Registration Number
NCT04575038
Locations
🇺🇸

Central Alabama Research, Homewood, Alabama, United States

🇺🇸

Ark Clinical Research, Long Beach, California, United States

🇺🇸

Doral Medical Research, Doral, Florida, United States

and more 11 locations

Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19

Phase 1
Completed
Conditions
COVID-19
Interventions
Other: Standard of Care
First Posted Date
2020-06-11
Last Posted Date
2022-02-17
Lead Sponsor
Clear Creek Bio, Inc.
Target Recruit Count
25
Registration Number
NCT04425252
Locations
🇺🇸

Hartford Hospital, Hartford, Connecticut, United States

🇺🇸

Baptist Medical Center, Jacksonville, Florida, United States

🇺🇸

University of South Florida/Tampa General, Tampa, Florida, United States

and more 2 locations

A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1
Terminated
Conditions
Acute Myeloid Leukemia
Interventions
First Posted Date
2018-11-30
Last Posted Date
2022-08-08
Lead Sponsor
Clear Creek Bio, Inc.
Target Recruit Count
17
Registration Number
NCT03760666
Locations
🇺🇸

City of Hope, Duarte, California, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Beth-Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 3 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath